Gilead Research Scholars Gilead Research Scholars
  • Subscribe
  • Available Programs |
  • Login / Register
Gilead Research Scholars
  • Program Information
    • Program Overview
    • Eligibility
    • Scientific Focus
    • Selection Process and Scoring Criteria
    • Scientific Review Committee
  • Application Information
    • Application Overview
    • Proposal & Budget Guidelines
    • Program Timeline
    • Inquiries/Contact Information
    • Downloads
  • Award Recipients
  • Apply
  • Contact
  • FAQ

 

Below are Gilead’s Research Scholar Program Hematologic Malignancies Awardees and their research titles. As the program values diverse voices and innovative research topics to address areas of unmet medical need, you do not need to duplicate previous research topics in order to be successful for an Award. 

Any clinical or basic research proposal that addresses an area of unmet medical need in Hematologic Malignancies is welcome.

For other examples of exceptional applications, please visit the NIH’s RO1 sample applications through this helpful resource: https://www.niaid.nih.gov/grants-contracts/sample-applications

 

2022 Award Recipients 

Award Recipient Image

Theodore P. Braun, MD, PhD

Oregon Health & Science University

Therapeutic Targeting of YBX1 in Myeloid Malignancies

Award Recipient Image

Sizun Jiang, PhD

Beth Israel Deaconess Medical Center

Spatial-temporal dynamics of CAR and non-CAR T cell orchestrated immune responses in the intact DLBCL tumor microenvironment

Award Recipient Image

Paolo Strati, MD

UT MD Anderson Cancer Center

Targeting Macrophages for the Treatment of B-cell Lymphoma

2020 Award Recipients 

Award Recipient Image

Christopher Ott, PhD

Massachusetts General Hospital

Investigation of a novel bromodomain addiction in multiple myeloma

Award Recipient Image

Maria Guillamot Runao, PhD, PharmD

NYU Langone

Epigenetic mechanisms of clonal evolution triggered by infections

Award Recipient Image

Alan Shih, MD, PhD

Icahn School of Medicine at Mount Sinai

TET2 and Inflammation in Myeloid Disease

Award Recipient Image

Anastasia Tikhonova, PhD

Princess Margaret Cancer Center

Dissecting Immune Microenvironment of adult T-cell acute lymphoblastic leukemia

2019 Award Recipients

Award Recipient Image

Julia Maxson, PhD

Oregon Health & Science University

“Mechanisms of SETBP1-driven Oncogenesis in Myeloid Leukemia”

Award Recipient Image

Marco Ruella, MD, MS

University of Pennsylvania

“Genetic Inactivation of CD5 in Normal T Cells to Enable Safe and Effective CAR T Cell Immunotherapy for T cell Lymphomas”

Award Recipient Image

Peter van Galen, PhD

Harvard Medical School

“Targeting Survival Mechanisms of Persistent Acute Myeloid Leukemia Cells”

2018 Award Recipients

Award Recipient Image

Saad S. Kenderian, MD

Mayo Clinic

"Depletion of GM-CSF and Myeloid Cells as a Strategy to Enhance The Therapeutic Index After Chimeric Antigen Receptor T (CART) Cell Therapy"

Award Recipient Image

Robert Kridel, MD, MPH, PhD

Princess Margaret Cancer Centre

"Rational Prioritization of Drug Combinations to Overcome Resistance to Tazemetostat in Germinal Centre B-cell Lymphoma"

Award Recipient Image

Xiaolei Su, PhD

Yale School of Medicine

"Molecular Mechanism of CAR Activation in Targeting B Cell Leukemia and Lymphoma"

2017 Award Recipients

Award Recipient Image

Sergei Doulatov, PhD

University of Washington

“Patient-Derived MDS Stem Cells from Pluripotent Stem Cells”

Award Recipient Image

Alex F. Herrera, MD

Beckman Research Institute of City of Hope

“Immunogenic Chemotherapy and Checkpoint Inhibition for Transformed Diffuse Large B-Cell Lymphoma”

Award Recipient Image

Panagiotis Ntziachristos, PhD

Northwestern University

“Targeting Aberrant Levels of the Splicing Factor SF3B1 as a Therapeutic Strategy in High-Risk T-Cell Leukemia"

2016 Award Recipients

Award Recipient Image

Emily Curran, MD

University of Chicago

“Immunologic Role of DDX41 in Development of Hereditary Hematologic Malignancies”

Award Recipient Image

Gang Greg Wang, PhD

University of North Carolina, Chapel Hill

“Decipher and Target Epigenetic Dependency in Acute Myeloid Leukemia with DNMT3A Mutation”

Award Recipient Image

Britta Will, PhD

Albert Einstein College of Medicine

“Targeting Chaperone-Mediated Autophagy for the Eradication of Acute Myeloid Leukemia”

2015 Award Recipients

Award Recipient Image

Steven Chan, MD, PhD

Princess Margaret Cancer Center University of Toronto

“Determination of the Clonal Architecture and Functional Impact of Mitochondrial DNA Mutations in Acute Myeloid Leukemia”

Award Recipient Image

Shangqin Guo, PhD

Yale University Stem Cell Center

“Molecular Definition of Leukemia Cell-of-Origin”

Award Recipient Image

Raajit Rampal, MD, PhD

Memorial Sloan Kettering Cancer Center

“Identification of Novel Therapeutic Strategies for Acute Myeloid Leukemia Arising from a Myeloproliferative Neoplasm”

2014 Award Recipients

Award Recipient Image

Luca Busino, PhD

University of Pennsylvania

“Relevance of KLHL6-mediated Protein Degradation in the Pathogenesis of B-cell Lymphoma”

Award Recipient Image

Phuong Doan, MD

Duke University

“Epidermal Growth Factor Regulates MDS Stem Cell Fate”

  • GILEAD and the GILEAD logo are registered trademarks of Gilead Sciences, Inc., or one of its related companies. Kite and the Kite Logo are registered trademarks of Kite, a Gilead company.
  • © 2022 Gilead Sciences, Inc. All rights reserved.
  •  
  •  

GILEAD and the GILEAD logo are registered trademarks of Gilead Sciences, Inc., or one of its related companies.

© 2020 Gilead Sciences, Inc. All rights reserved. 

Privacy Policy 

Terms of Use 

Funding Considerations